KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Long-Term Investments (2016 - 2026)

Biogen has reported Long-Term Investments over the past 17 years, most recently at $465.6 million for Q1 2026.

  • For Q1 2026, Long-Term Investments changed N/A year-over-year to $465.6 million; the TTM value through Mar 2026 reached $465.6 million, changed N/A, while the annual FY2025 figure was $431.9 million, N/A changed from the prior year.
  • Long-Term Investments for Q1 2026 was $465.6 million at Biogen, up from $431.9 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $1.2 billion in Q2 2023 and troughed at $100000.0 in Q3 2023.
  • A 4-year average of $750.5 million and a median of $860.3 million in 2022 define the central range for Long-Term Investments.
  • Biggest five-year swings in Long-Term Investments: grew 21.86% in 2022 and later tumbled 99.99% in 2023.
  • Year by year, Long-Term Investments stood at $705.7 million in 2022, then plummeted by 99.99% to $100000.0 in 2023, then soared by 431800.0% to $431.9 million in 2025, then rose by 7.8% to $465.6 million in 2026.
  • Business Quant data shows Long-Term Investments for BIIB at $465.6 million in Q1 2026, $431.9 million in Q4 2025, and $100000.0 in Q3 2023.